Search

Search Constraints

You searched for: Author/Creator Walter, Roland

Search Results

1. Comparative proteomics reveals a diagnostic signature for pulmonary head‐and‐neck cancer metastasis. Issue 9 (10th August 2018)

2. Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Issue 1 (December 2016)

3. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Issue 1 (December 2015)

4. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Issue 1 (December 2015)

5. Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms. Issue 11 (November 2018)

6. Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high‐risk MDS. (16th November 2015)

7. Rapid X-ray variability in Mkn 421 during a multiwavelength campaign. Issue 2 (7th April 2022)